Core Viewpoint - Huasheng Technology (000790) announced the transfer of its "smokeless moxibustion stick market authorization rights and related technology" to Sichuan Binjiang Pharmaceutical Co., Ltd. for a total amount of 18 million yuan (including tax) [1] Group 1 - The transfer aims to optimize asset allocation and focus on core business areas [1] - The business scale of the smokeless moxibustion stick product has not significantly impacted the company's performance [1] - This collaboration is expected to revitalize the company's existing pharmaceutical resources, optimize product structure, and enhance asset operational efficiency [1] Group 2 - The recovery of funds from this transaction will support the company's core strategic development and subsequent resource integration [1] - The move is intended to further strengthen the company's competitive position in its main business [1]
华神科技分公司拟对外转让无烟灸条上市许可持有人权益及相关技术